About
Technology
Issues
FAQ
Links
Official Page
Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.